The Exchange has sought clarification from Sakar Healthcare Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act. -2. 2013 or as per Indian Accounting Standard. The response of the Company is awaited.
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE has asked Sakar Healthcare to clarify its financial results for the quarter ended 31 December 2025, citing that the submission does not follow the format prescribed under Schedule III of the Companies Act, 2013, or Indian Accounting Standards (Ind AS). The company is yet to respond to the exchange's queries. This is a procedural compliance issue related to how the results were reported, not necessarily a reflection on the underlying numbers. Investors should wait for the company's response to understand if any restatement or correction is needed.
This is a minor compliance flag and unlikely to materially affect the stock in the short term, but any non-compliance with reporting formats could delay approval of results and may raise governance concerns among investors.